Distant lymph node metastasis of early gastric cancer. 1997

H Isozaki, and K Okajima, and T Ichinona, and K Fujii, and E Nomura, and N Izumi, and T Ohyama
Department of Surgery, Osaka Medical College, Japan.

Among 601 patients with early gastric cancer (EGC), the clinicopathological findings of 5 patients (invasion of the mucosal layer in 2 and of the submucosal layer in 3) with distant lymph node metastasis according to TNM classification (third- or fourth-tier lymph node metastasis according to the Japanese classification) were investigated. The proliferating-cell nuclear antigen (PCNA) expression of EGC was also examined immunohistologically. The sites of distant metastasis were the nodes at the root of the mesentery, in the hepatoduodenal ligament, and the paraaortic nodes. While the PCNA-positive rate of EGC with distant lymph node metastasis (35.4%) was significantly higher than that of EGC without lymph node metastasis (14.7% P = 0.01), it was similar to that of EGC with perigastric lymph node metastasis. The cumulative survival rate of the EGC patients with distant lymph node metastasis (5-year survival rate 20.0%) was significantly lower than that without lymph node metastasis (88.2%, P < 0.0001), first-tier lymph node metastasis (76.9%, P < 0.04), or second-tier lymph node metastasis (77.1%, P < 0.04). Thus, although the prognosis of EGC patients with distant lymph node metastasis was poor, a dissection of the distant lymph nodes should be performed when metastasis is suspected.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002291 Carcinoma, Papillary A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed) Carcinomas, Papillary,Papillary Carcinoma,Papillary Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

H Isozaki, and K Okajima, and T Ichinona, and K Fujii, and E Nomura, and N Izumi, and T Ohyama
August 1969, Gan no rinsho. Japan journal of cancer clinics,
H Isozaki, and K Okajima, and T Ichinona, and K Fujii, and E Nomura, and N Izumi, and T Ohyama
January 2014, Revista do Colegio Brasileiro de Cirurgioes,
H Isozaki, and K Okajima, and T Ichinona, and K Fujii, and E Nomura, and N Izumi, and T Ohyama
January 1997, The Kurume medical journal,
H Isozaki, and K Okajima, and T Ichinona, and K Fujii, and E Nomura, and N Izumi, and T Ohyama
January 2014, Chinese medical journal,
H Isozaki, and K Okajima, and T Ichinona, and K Fujii, and E Nomura, and N Izumi, and T Ohyama
April 2011, Annals of surgery,
H Isozaki, and K Okajima, and T Ichinona, and K Fujii, and E Nomura, and N Izumi, and T Ohyama
January 1986, International surgery,
H Isozaki, and K Okajima, and T Ichinona, and K Fujii, and E Nomura, and N Izumi, and T Ohyama
September 1988, Nihon Geka Gakkai zasshi,
H Isozaki, and K Okajima, and T Ichinona, and K Fujii, and E Nomura, and N Izumi, and T Ohyama
March 1991, The European journal of surgery = Acta chirurgica,
H Isozaki, and K Okajima, and T Ichinona, and K Fujii, and E Nomura, and N Izumi, and T Ohyama
May 2014, World journal of gastroenterology,
H Isozaki, and K Okajima, and T Ichinona, and K Fujii, and E Nomura, and N Izumi, and T Ohyama
January 1995, The Kurume medical journal,
Copied contents to your clipboard!